# Fast food consumption and risk of non-alcoholic fatty liver disease: a systematic review and meta-analysis

**Authors:** Jinke He, Yingxue Wang, Fangbin Weng

PMC · DOI: 10.3389/fpubh.2025.1600826 · 2025-07-30

## TL;DR

Eating fast food is linked to a higher risk of non-alcoholic fatty liver disease and obesity, according to a review of multiple studies.

## Contribution

This study provides a meta-analysis showing a strong association between fast food consumption and NAFLD risk.

## Key findings

- Fast food intake increases NAFLD risk by 55%.
- Fast food is linked to a 37% higher risk of obesity.
- Findings are robust with no significant publication bias.

## Abstract

Non-alcoholic fatty liver disease (NAFLD) is a global health issue, with fast food consumption hypothesized as a risk factor. This meta-analysis aimed to explore the relationship between fast food intake and NAFLD.

This review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. A comprehensive search was conducted across PubMed, Web of Science, Scopus, and Embase from inception to February 28, 2025. A total of nine eligible observational studies involving 169,771 participants were included. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models.

A higher consumption of fast food was significantly associated with a 55% increased risk of NAFLD (OR = 1.55, 95% CI: 1.51–1.59, p < 0.001, I2 = 15.6%). Moreover, fast food intake was linked to a 37% higher risk of obesity (OR = 1.37, 95% CI: 1.27–1.49, p < 0.001, I2 = 54.2%), a key metabolic factor in NAFLD pathogenesis. Sensitivity analysis confirmed the robustness of these associations, with no significant evidence of publication bias.

Fast food consumption is positively associated with NAFLD and obesity. Heterogeneity highlights the need for standardized methods in future large-scale studies to validate these findings and inform preventive strategies.

## Linked entities

- **Diseases:** non-alcoholic fatty liver disease (MONDO:0013209), obesity (MONDO:0011122)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** adipose (MESH:D018205), hepatitis A, B, and C (MESH:D006509), type 2 diabetes (MESH:D003924), hepatic inflammation (MESH:D007249), fatty liver (MESH:D005234), ectopic fat (MESH:D004620), endotoxemia (MESH:D019446), Associated (Non-Alcoholic) Fatty Liver Disease (MESH:D065626), liver condition (MESH:D017093), hepatocellular carcinoma (MESH:D006528), Wilson's disease (MESH:D006527), visceral adiposity (MESH:D007418), Metabolic Dysfunction (MESH:D008659), NASH (MESH:D005235), Obesity (MESH:D009765), cirrhosis (MESH:D005355), insulin resistance (MESH:D007333), chronic liver diseases (MESH:D008107), liver fibrosis (MESH:D008103), metabolic syndrome (MESH:D024821), CAP (OMIM:115650)
- **Chemicals:** sugars (MESH:D000073893), alcohol (MESH:D000438), sodium (MESH:D012964), unsaturated fatty acid (MESH:D005231), triacylglycerol (MESH:D014280), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343633/full.md

---
Source: https://tomesphere.com/paper/PMC12343633